Markets:

Overview

News

Currencies

International

Treasuries

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

41.03 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Apellis Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

14 Analysts Have This to Say About Apellis Pharmaceuticals ↗

December 05, 2023

Via Benzinga

Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

December 05, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Magnificent 7 Take Center Stage In Hedge Fund Portfolios: Analysts Warn Of Extreme Concentration ↗

November 21, 2023

Hedge fund portfolios are intensifying their focus on technology stocks, with holdings in mega-cap tech reaching record levels.

Via Benzinga

Why Is Apellis Pharmaceuticals Stock Trading Lower Today? ↗

November 06, 2023

Shares of Apellis Pharmaceuticals Inc (NASDAQ: APLS) declined following a

Via Benzinga

21 Analysts Have This to Say About Apellis Pharmaceuticals ↗

November 02, 2023

Via Benzinga

Analyst Ratings for Apellis Pharmaceuticals ↗

October 06, 2023

Via Benzinga

Why Apellis Pharmaceuticals Stock Popped Today ↗

October 05, 2023

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) shares are trading higher Thursday after the company reported preliminary U.S.

Via Benzinga

Why Shares of Apellis Pharmaceuticals Were Down Wednesday ↗

September 27, 2023

A short-seller report sent the stock tumbling.

Via The Motley Fool

Inside Cathie Wood’s Portfolio: 3 Stocks She Is Betting Millions On ↗

November 01, 2023

Are you looking to invest in disrupting stocks like Cathie Woods? Here are three stocks Cathie Wood is betting millions on.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

October 31, 2023

Via Benzinga

Apellis Pharmaceuticals Stock Improves With An RS Ratings Over 90 ↗

October 31, 2023

Apellis Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Apellis Pharmaceuticals Stock Shows Rising Relative Strength ↗

October 24, 2023

A Relative Strength Rating upgrade for Apellis Pharmaceuticals shows improving technical performance. Will it continue?

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

October 18, 2023

Via Benzinga

Analyst Ratings for Apellis Pharmaceuticals ↗

September 14, 2023

Via Benzinga

Where Apellis Pharmaceuticals Stands With Analysts ↗

August 24, 2023

Via Benzinga

Stocks Mixed Amid Earnings, Consumer Sentiment Data ↗

October 13, 2023

Stocks are mixed this afternoon, as investors unpack earnings reports from several bank giants as well as economic data.

Via Talk Markets

JPMorgan, Wells Fargo, Citigroup And Other Big Stocks Moving Higher On Friday ↗

October 13, 2023

U.S. stocks traded mostly higher, with the Dow Jones gaining more than 100 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why Pioneer Natural Resources Shares Are Bouncing By Around 12%; Here Are 20 Stocks Moving Premarket ↗

October 06, 2023

Gainers Vaccinex, Inc. (NASDAQ: VCNX) shares rose 40.2% to $1.15 in pre-market trading as two large insider buys were reported after the close on Thursday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 ↗

October 06, 2023

Via Benzinga

Constellation Brands To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Friday ↗

October 06, 2023

HSBC raised the price target for Constellation Brands, Inc. (NYSE: STZ) from $280 to $290. HSBC analyst Carlos Laboy maintained a Buy rating. Constellation shares fell 3.2% to close at $241.33 on...

Via Benzinga

Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 27, 2023

Gainers

Via Benzinga

Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday ↗

September 15, 2023

B of A Securities raised the price target for Unity Software Inc. (NYSE: U) from $46 to $56. B of A Securities analyst Ryan Gee upgraded the stock from Neutral to Buy. Unity Software shares fell 3% to...

Via Benzinga

Why Is Apellis Pharmaceuticals Stock Trading Lower Today? ↗

August 29, 2023

Apellis Pharmaceuticals Inc (NASDAQ: APLS) revealed a comprehensive corporate restructuring plan aimed at catalyzing the growth of its flagship products, Syfovre (pegcetacoplan injection) and

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2023 ↗

September 15, 2023

Via Benzinga

Catalent (CTLT) Stock Gains on Elliott Deal ↗

August 29, 2023

Catalent (CTLT) stock is getting a boost on Tuesday after the company reached an agreement with Elliott Investment Management.

Via InvestorPlace

Apellis Layoffs 2023: What to Know About the Latest APLS Job Cuts ↗

August 29, 2023

Apellis Pharmaceuticals (APLS) layoffs are a hot topic on Tuesday as the commercial-stage biopharmaceutical company prepares for job cuts.

Via InvestorPlace

Topics Workforce

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet ↗

August 25, 2023

Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be...

Via Benzinga

3 Very Oversold Pharma Stocks to Buy Right Now ↗

August 24, 2023

Oversold pharma stocks have great total return potential. In this article, we list some of the best to buy.

Via InvestorPlace

Apellis Pharma's Newly Launched Eye Drug Set For Resilient Performance, Syfovre Update Sparks Optimism ↗

August 23, 2023

HC Wainwright says the relative lack of new cases is a positive and should jumpstart Apellis Pharmaceuticals Inc (NASDAQ: APLS) Syfovre,

Via Benzinga

S&P 500 Gains 1%; Analog Devices Posts Downbeat Results ↗

August 23, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Wednesday. The Dow traded up 0.51% to 34,462.61 while the NASDAQ rose 1.60% to 13,722.24....

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.